In multivariate survival analysis, the expressions of MME and SERPINA9 were prognostic factors independent of COO, suggesting that these genes have other effects on CD5+ DLBCL, as opposed to simply representing markers for the GCB subtype. The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.